These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33214256)

  • 21. SARS-CoV-2 Reinfections during the Delta Variant Surge - Missouri, June-October, 2021.
    Turabelidze G; Womack AJ; Mobley E; Garikapaty V; Finley S
    Mo Med; 2021; 118(6):539. PubMed ID: 34924621
    [No Abstract]   [Full Text] [Related]  

  • 22. Viral dynamics in the Upper Respiratory Tract (URT) of SARS-CoV-2.
    Tirupathi R; Ramparas TR; Wadhwa G; Areti S; Kaur J; Salim S; Rabaan AA; Al-Tawfiq JA
    Infez Med; 2020 Dec; 28(4):486-499. PubMed ID: 33257622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection.
    Fialkowski A; Gernez Y; Arya P; Weinacht KG; Kinane TB; Yonker LM
    Pediatr Pulmonol; 2020 Oct; 55(10):2556-2564. PubMed ID: 32710693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The known unknowns of T cell immunity to COVID-19.
    Karlsson AC; Humbert M; Buggert M
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
    Schwarzkopf S; Krawczyk A; Knop D; Klump H; Heinold A; Heinemann FM; Thümmler L; Temme C; Breyer M; Witzke O; Dittmer U; Lenz V; Horn PA; Lindemann M
    Emerg Infect Dis; 2021 Jan; 27(1):. PubMed ID: 33058753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data.
    McMahon A; Robb NC
    JMIR Public Health Surveill; 2020 Nov; 6(4):e21168. PubMed ID: 33052872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent viral shedding in respiratory samples of patients with SARS-CoV-2: observational analysis with infection control implications.
    AlJishi JM; Al-Tawfiq JA
    J Hosp Infect; 2021 Jan; 107():98-100. PubMed ID: 32920017
    [No Abstract]   [Full Text] [Related]  

  • 29. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?
    Pal R; Banerjee M
    Prim Care Diabetes; 2021 Feb; 15(1):18-20. PubMed ID: 32800450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms.
    Neumann B; Schmidbauer ML; Dimitriadis K; Otto S; Knier B; Niesen WD; Hosp JA; Günther A; Lindemann S; Nagy G; Steinberg T; Linker RA; Hemmer B; Bösel J;
    J Neurol Sci; 2020 Nov; 418():117090. PubMed ID: 32805440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PCR for COVID-19 positive, then negative and again positive Reinfection at 55 days?].
    Martín Enguix D; Aguirre Rodríguez JC; Sánchez Cambronero M; Hidalgo Rodríguez A
    Semergen; 2021 Apr; 47(3):207-208. PubMed ID: 33478840
    [No Abstract]   [Full Text] [Related]  

  • 33. Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2.
    Uwamino Y; Nagata M; Aoki W; Fujimori Y; Nakagawa T; Yokota H; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Shiraki T; Uchida S; Uno S; Kabata H; Ikemura S; Kamata H; Ishii M; Fukunaga K; Kawaoka Y; Hasegawa N; Murata M
    J Clin Pathol; 2021 Jan; 74(1):67-68. PubMed ID: 32928941
    [No Abstract]   [Full Text] [Related]  

  • 34. Cautionary Note on Contamination of Reagents Used for Molecular Detection of SARS-CoV-2.
    Huggett JF; Benes V; Bustin SA; Garson JA; Harris K; Kammel M; Kubista M; McHugh TD; Moran-Gilad J; Nolan T; Pfaffl MW; Salit M; Shipley G; Vallone PM; Vandesompele J; Wittwer C; Zeichhardt H
    Clin Chem; 2020 Nov; 66(11):1369-1372. PubMed ID: 32894756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
    Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.
    Dias SSG; Soares VC; Ferreira AC; Sacramento CQ; Fintelman-Rodrigues N; Temerozo JR; Teixeira L; Nunes da Silva MA; Barreto E; Mattos M; de Freitas CS; Azevedo-Quintanilha IG; Manso PPA; Miranda MD; Siqueira MM; Hottz ED; Pão CRR; Bou-Habib DC; Barreto-Vieira DF; Bozza FA; Souza TML; Bozza PT
    PLoS Pathog; 2020 Dec; 16(12):e1009127. PubMed ID: 33326472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 reinfection - An enigmatic public health threat.
    Iyengar KP; Jain VK; Ish P
    Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33305559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivation or reinfection of COVID-19 disease?
    Özdemir Ö
    J Med Virol; 2022 Jan; 94(1):17. PubMed ID: 34415631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.